In the context of the brain, recent reports have shown that removing senescent cells improves phenotypes in mouse models of Parkinson’s disease (Chinta et al., 2018) and tau-dependent neurodegenerative diseases (Musi et al., 2018, Bussian et al., 2018). This evidence concerns the gene MAPT and neurodegenerative disease.